Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures

Size: px
Start display at page:

Download "Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures"

Transcription

1 Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures 2011 The University of Texas at Austin IC2 Institute 1

2 Overview Review of Traditional Innovation Models Presentation of Technology Innovation Model 2.0 Engineering Commercialization into Innovation The Emergent Technology Model Principal Commercialization Strategies Reaching Industry with Innovation Industry Seeking Innovation Conclusions Discussion 2011 The University of Texas at Austin IC2 Institute 2

3 Traditional Innovation Models 2011 The University of Texas at Austin IC2 Institute 3

4 Traditional Commercialization Model $ Funding $ Science Innovation Commercialization 2011 The University of Texas at Austin IC2 Institute 4

5 Trends in Basic R&D Funding in US FY in billions of constant FY 2008 USD 2011 The University of Texas at Austin IC2 Institute 5 Source: AAAS Analyses of R&D in AAAS Reports VIIII

6 Trends in US Venture Capital Investment Important Variables Stage of Development Location Connections Dilution/Deal Structure Venture Capital Investments ($ millions) 2011 The University of Texas at Austin IC2 Institute 6 Source: Bio.org 2009

7 Traditional Model Works but Poorly In 2009 ~$131 billion total R&D spending by US government ~$54 billion in research funding (>$40 billion in healthcare) to reporting entities ~$2.3 billion in licensing income to reporting entities >18,000 patents filed, >3,400 patents issued in US ~600 new companies formed ~4% of annual reported research spending, and <2% of all R&D spending returned in realized commercialization. Slowing and refocusing of Venture Capital 2011 The University of Texas at Austin IC2 Institute 7 Source: AUTM; AAAS Reports

8 A Cue From Edison Market Need: The Light Bulb Most know the end of the story Edison tried more than 6,000 different filaments to identify one that would burn for a few hours. Most do not know Edison was not the first to invent the incandescent light bulb. Indeed, Joseph Swan actually obtained the first patent a year before Edison s patent date The University of Texas at Austin IC2 Institute 8 Source: At Work with Thomas Edison, Blaine McCormick, 2001.

9 A Cue From Edison The Rest of the Story More surprisingly Edison was the 23rd person to file a patent for the light bulb. Edison s bulb was by far the most commercially successful. He was the only one who made the use of a light bulb practical for commercial use envisioning an electrical power industry and market deployment. Successful innovation required a commercial perspective or we would all find ourselves in the dark! 2011 The University of Texas at Austin IC2 Institute 9 Source: At Work with Thomas Edison, Blaine McCormick, 2001.

10 Technology Innovation The University of Texas at Austin IC2 Institute 10

11 Commercialization Must be Engineered into Innovation Institutional technology innovation is just the raw material. Commercialization involves a strategy integrating simultaneous development of: Science/technology enablement Intellectual property protection Market fit Business reach and execution Commercialization = Innovation + Strategy + Funding + Execution Commercialization is executed according to an marketdriven strategy with timing-based adaptability The University of Texas at Austin IC2 Institute 11

12 Emergent Technologies, Inc. Overview Formed as consultancy in 1989, first fund in 1999 $50 million under management (four funds) Leveraged into >$500 million through industry partnerships Commercial focus early stage university innovation 19 portfolio companies managed >100 transactions executed in the last 18 months >350 patents under management 2011 The University of Texas at Austin IC2 Institute 12 Source: AUTM; AAAS Reports

13 ETI Services Provide management services to portfolio companies including Business development, legal review, IP strategy and execution, strategic asset management (finance and liquidity) AR/AP, HR and benefit plans, grant support, marketing, public relations, others The ETI approach offers Low overhead Synergy of a large, diverse team Expanded commercial reach 2011 The University of Texas at Austin IC2 Institute 13

14 ETI Affinity Funds and Portfolio Companies Texas Tech University System University of Texas System Funds I and II Fund III Fund VI University of Oklahoma Texas Tech University System University of Texas System 2011 The University of Texas at Austin IC2 Institute 14

15 ETI Innovation Services Assisting communities realize the potential of underutilized technology assets Technology evaluation Business recruitment Strategic plan implementation Company management Existing deals: Abilene, TX Abilene Life Science Accelerator management Lea County, NM Respira, LLC Cottonwood Technology Fund 2011 The University of Texas at Austin IC2 Institute 15

16 Engineering Commercialization Principal approaches: Reaching industry with innovation Industry seeking innovation 2011 The University of Texas at Austin IC2 Institute 16

17 Reaching Industry with Innovation 2011 The University of Texas at Austin IC2 Institute 17

18 Categories of Innovation Not able to protect with IP Out-licensing -- add-on value Know the need for invention Value proposition Sell into that space Document and use valuation tools Be creative in deal structure Do the deal Platform technologies differ from incremental improvements in that they Multiple uses can be protected Offer multiple applications Offer potential basis for a new venture 2011 The University of Texas at Austin IC2 Institute 18

19 Collaborative Innovation Engineering Engage a network of advisors and adjunct scientific team under confidentiality to Explore alternative perspectives Further improve or bundle innovations to produce robust market solutions Establish rapid proof of concept for specified applications Engage Industry leaders about need and fit. Of 19 companies, 17 are focused on different product strategies than the inventor and institution pitched to ETI. Contact lenses to orthodontics Dermal fillers to drug formulation Contact lenses to apparel 2011 The University of Texas at Austin IC2 Institute 19

20 The Technology Innovation Process Innovation model Transforms scientific breakthroughs into commercially-driven platforms Enables efficient management of both cost and risk Accelerates product success through partnerships with industry leaders Provides industry partners opportunity to license or acquire patented technologies providing near term impact on both revenue growth and value 2011 The University of Texas at Austin IC2 Institute 20

21 Selected Examples: Company Progress Hyalose, L.L.C. Partner: Novozymes $90 million in leverage of capital Product: HyaCare Gold Innovation Award CPhI worldwide conference 2008 Selenium, Ltd. Partner: ClassOne Orthodontics Product: SeLECT Orthodontics Product Line (2 FDA approvals) Pure Protein, L.L.C. Partners: Fortune 100 and 500 companies for transplantrelated immunodiagnostic assays Partner: OK EDGE Grant $1.8 million for development of prototype transplantation therapeutic device 2011 The University of Texas at Austin IC2 Institute 21

22 ETI Financial Leveraging Aggregate Cost Sharing Across ETI Portfolio 2011 The University of Texas at Austin IC2 Institute 22

23 Industry Seeking Innovation 2011 The University of Texas at Austin IC2 Institute 23

24 Merck ETI Collaboration Merck & Co. acquired SIRNA for $1.1 billion in 2007 Platform for drug lead and MOA confirmation New therapeutic drug strategy Broad applications of same composition mouse to human Complex delivery to target cells, then to active site Merck & Co. engaged ETI to Provide expanded reach, technology bundling, rapid deal cycling, funding source and project management Develop sirna delivery toward a defined technical outcome and financial return 2011 The University of Texas at Austin IC2 Institute 24

25 Areas of Focus Oral -- Gut uptake with efficiency and capacity Central Nervous System -- Requires BBB endothelial cell specificity Subcutaneous or Transcutaneous -- Treatment of systemic or local diseases Deep Lung -- Eliminate first pass metabolism Each offers Potential for superior systemic delivery Local delivery and application 2011 The University of Texas at Austin IC2 Institute 25

26 Merck ETI Structure Stage 1: Technology Identification and Evaluation >400 technologies reviewed >100 patents reviewed 10 NDAs in place Stage 2: Technology Leads One deal oral delivery Two deals pulmonary delivery One deal subcutaneous delivery Stage 3: Technology Demonstration Defined de-risking milestones with specifications Defined exit value Stage 4: Technology Licensing / Acquisition 2011 The University of Texas at Austin IC2 Institute 26

27 Cue From Edison Take 2 Carbolic acid a key constituent in explosives - also critical to production of phonographic records Supply cut off from Europe during first world war. Chemists assured [Edison] it would take at least six months to generate a supply The University of Texas at Austin IC2 Institute 27 Source: At Work with Thomas Edison, Blaine McCormick, 2001.

28 Cue From Edison Take 2 Within 72 hours, Edison had derived a large scale process for one of the known synthetic routes. Edison identified 40 variedly skilled personnel (drafting, chemistry, etc.) and teamed them together in round the clock groups. 24 days later Edison s new plant began to deliver carbolic acid The University of Texas at Austin IC2 Institute 28 Source: At Work with Thomas Edison, Blaine McCormick, 2001.

29 Merck-ETI Development Network Teams are formed involving scientists in and outside the ETI portfolio to provide experimental support (primarily in Austin, TX area) and advisory services (world-wide) relating to: Formulation Properties In Vitro, Cellular, Studies In Vivo Studies Small Animals In Vivo Studies Large Animals 2011 The University of Texas at Austin IC2 Institute 29

30 Conclusions Innovation must be managed to achieve commercial endpoints Successful management of innovation requires: Effective innovation evaluation A clearly designed commercial trajectory Full service, low overhead Focus on execution Creative funding sources are necessary Effective execution of technical, intellectual property and business strategy providing investor return is crucial The University of Texas at Austin IC2 Institute 30

31 Questions for Consideration How does the market drive the development of innovation in your organization? How do you currently reach out to the marketplace? What are the key development hurdles that must be derisked for commercialization of your innovation? What differentiating expertise does your organization offer? What local capabilities (corporate and academic) can be networked to facilitate development of technologies? How are you creatively accessing capital resources? 2011 The University of Texas at Austin IC2 Institute 31

32 Gregory P. Pogue, Ph.D. University of Texas at Austin, IC 2 Institute 2815 San Gabriel Austin, TX office

Best Practices for Launching Tech Ventures and Leveraging the University Mission Funding Strategies

Best Practices for Launching Tech Ventures and Leveraging the University Mission Funding Strategies Best Practices for Launching Tech Ventures and Leveraging the University Mission Funding Strategies 2011 The University of Texas at Austin IC2 Institute 1 Overview Forces Impacting Capital Availability

More information

Managing Expectations

Managing Expectations Managing Expectations The role of a founder Founders versus managers Not all founders are good managers Roles change over time Start-up business plans change a lot! Goal Synergy: Compensation: cash or

More information

Biomedical Accelerator Fund. Office of Technology Development Harvard University

Biomedical Accelerator Fund. Office of Technology Development Harvard University Biomedical Accelerator Fund Office of Technology Development Harvard University Curtis Keith, Chief Scientific Officer May 21, 2012 Mission of Harvard s Office 2 Organizational Structure of Harvard OTD

More information

Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

Pennino Corporation TECHNOLOGY TO IMPROVE LIFE Pennino Corporation TECHNOLOGY TO IMPROVE LIFE Agenda The Opportunity Highlights Corporate Profile NYU Relationship Obesity and Diabetes Graphics and Facts Next Stage of Development Efficacy and Safety

More information

Transforming relationships Unleashing innovation

Transforming relationships Unleashing innovation Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries

More information

Tech Launch Arizona. Start-up Guide For New Companies Licensing Technologies Invented at the University of Arizona

Tech Launch Arizona. Start-up Guide For New Companies Licensing Technologies Invented at the University of Arizona Tech Launch Arizona Start-up Guide For New Companies Licensing Technologies Invented at the University of Arizona Contents The Idea-to-Impact Continuum... 1 The TLA Start-up Pathway... 3 1. Investigator:

More information

The Commercialization of Technology Concepts into Medical Products

The Commercialization of Technology Concepts into Medical Products The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

Eudendron: an Innovative Biotech Start-up

Eudendron: an Innovative Biotech Start-up Eudendron: an Innovative Biotech Start-up Mauro Angiolini & Fabio Zuccotto I Venti dell Innovazione, Ville Ponti - Varese, 20 Marzo 2013 Bioindustry Park S. Fumero (Ivrea) - Italy Eudendron: a Quick Description

More information

From Data to Foresight:

From Data to Foresight: Laura Haas, IBM Fellow IBM Research - Almaden From Data to Foresight: Leveraging Data and Analytics for Materials Research 1 2011 IBM Corporation The road from data to foresight is long? Consumer Reports

More information

An Introduction to Valuations

An Introduction to Valuations An Introduction to Valuations PREPARED FOR ROCKY MOUNTAIN BIOBOOSTER MAY 9 TH, 2012 An ICON plc Company Agenda Introductions Valuation methods When is a valuation appropriate? How do you maximize your

More information

University of Arizona Libraries Initiates Successful Partnership with Campus Commercialization Unit: A Case Study

University of Arizona Libraries Initiates Successful Partnership with Campus Commercialization Unit: A Case Study University of Arizona Libraries Initiates Successful Partnership with Campus Commercialization Unit: A Case Study Cynthia Elliott, Research & Learning Librarian, M.A. University of Arizona Libraries, Tucson,

More information

The Experience of UK Technology Transfer Offices.

The Experience of UK Technology Transfer Offices. The Experience of UK Technology Transfer Offices. 28 th November 2012 Andrew Walsh, Manager, Healthcare Cambridge Enterprise Limited, University of Cambridge The Role of a Universities in the UK Mission

More information

University of Minnesota Start-up Guide

University of Minnesota Start-up Guide University of Minnesota Start-up Guide Office for Technology Commercialization (OTC) - Venture Center A guide for faculty, staff, and entrepreneurs interested in starting a new business based on University

More information

An integrated global healthcare company

An integrated global healthcare company An integrated global healthcare company 1 A Mission to create healthier communities globally Zydus Cadila is dedicated to life In all its dimensions. Our world is shaped by a passion for innovation, commitment

More information

The Cell Therapy Catapult

The Cell Therapy Catapult The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing

More information

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities

More information

Venture Development Fund Request for Proposals

Venture Development Fund Request for Proposals Venture Development Fund Request for Proposals Summary Oregon State University seeks to facilitate the further development of OSU applied innovations and commercialization. The purpose of this RFP is to

More information

New York StartUP! 2013 Business Plan Competition Company Profile

New York StartUP! 2013 Business Plan Competition Company Profile New York StartUP! 2013 Business Plan Competition Company Profile Company Name: Year Founded: Contact Name: Address: City State Zip: Target Market: Customer Problem: Email: p: f: URL: Industry: # Employees:

More information

STRATEGY OF OPEN JOINT-STOCK COMPANY RUSNANO UNTIL 2020

STRATEGY OF OPEN JOINT-STOCK COMPANY RUSNANO UNTIL 2020 Appendix 1 to protocol APPROVED by the Board of Directors of Open Joint Stock Company RUSNANO Protocol from 20 December 2013 #27 (section I) STRATEGY OF OPEN JOINT-STOCK COMPANY RUSNANO UNTIL 2020 Moscow

More information

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS

More information

Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing

Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,

More information

Advanced Materials & Technologies for the Solar and Semiconductor industry. The Merger of Two Leading Technology Companies

Advanced Materials & Technologies for the Solar and Semiconductor industry. The Merger of Two Leading Technology Companies Advanced Materials & Technologies for the Solar and Semiconductor industry The Merger of Two Leading Technology Companies ABOUT US HPQT is being created from the combination of Magnolia Solar and Solar

More information

For personal use only

For personal use only Integrated Research Limited (IRI) FY2015 Annual General Meeting 13 November, 2015 ABN: 76 003 588 449 9 of the top 10 US banks 4 of the world s 10 largest companies 6 of the 10 biggest stock exchanges

More information

BioBusiness Hyaluronic acid HyaCare. Hans Ole Klingenberg, Director, Hyaluronic acid

BioBusiness Hyaluronic acid HyaCare. Hans Ole Klingenberg, Director, Hyaluronic acid BioBusiness Hyaluronic acid HyaCare Hans Ole Klingenberg, Director, Hyaluronic acid 2 Novozymes solutions dedicated to the biopharmaceutical industry Formulation and drug delivery Recombumin HyaCare albucult

More information

Agenda Item 3. Discovery to Product Accelerator

Agenda Item 3. Discovery to Product Accelerator Agenda Item 3 Discovery to Product Accelerator BOARD OF REGENTS SUMMARY OF ITEM FOR ACTION INFORMATION OR DISCUSSION TOPIC: Discovery to Product Accelerator (information item) COMMITTEE: Economic Development

More information

The Future of Consumer Health Care

The Future of Consumer Health Care The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

More information

WTAS Valuation Services Group

WTAS Valuation Services Group WTAS Valuation Services Group Information & Overview March 2014 Presented to 1 Table of Contents I. WTAS Valuation Services Overview II. WTAS Overview III. Services Offering IV. Approach V. Professionals

More information

Photocure ASA. Exclusive global Licence Agreement for Lumacan with Salix Pharmaceuticals, Inc. 20 October 2010 Kjetil Hestdal, President & CEO

Photocure ASA. Exclusive global Licence Agreement for Lumacan with Salix Pharmaceuticals, Inc. 20 October 2010 Kjetil Hestdal, President & CEO Brilliance in photodynamic technology TM Photocure ASA Exclusive global Licence Agreement for Lumacan with Salix Pharmaceuticals, Inc. 20 October 2010 Kjetil Hestdal, President & CEO Agreement with Salix

More information

Turning ideas into reality.

Turning ideas into reality. June 27, 27, 2014 014 Diane Eustaquio Executive Director Turning ideas into reality. Who we are A non-profit organization that advocates technology development, innovation and entrepreneurship as a path

More information

Tsugio Yamamoto. Financial Institutions Business Unit / Government & Public Corporation Business Unit Business Strategy

Tsugio Yamamoto. Financial Institutions Business Unit / Government & Public Corporation Business Unit Business Strategy Financial Institutions Business Unit / Government & Public Corporation Business Unit Business Strategy Hitachi IR Day 2016 June 1, 2016 Tsugio Yamamoto CEO of Financial Institutions Business Unit CEO of

More information

Flamel Technologies Provides Update on Corporate Progress

Flamel Technologies Provides Update on Corporate Progress Flamel Technologies Provides Update on Corporate Progress Clinical Programs Continue to Move Forward Outlines Full Year 2016 Revenue Guidance Lyon, France January 8, 2016 - Flamel Technologies (NASDAQ:

More information

INTELLECTUAL PROPERTY STRATEGY

INTELLECTUAL PROPERTY STRATEGY OCEAN TOMO INTELLECTUAL PROPERTY STRATEGY At Ocean Tomo we begin each intellectual property (IP) Strategy Advisory Services engagement with a thorough understanding of relevant industry activity as well

More information

Merger & Acquisition, Integration and Divestiture

Merger & Acquisition, Integration and Divestiture Financial Services the way we do it Merger & Acquisition, Integration and Divestiture Financial institutions are re-focusing their M&A strategies and objectives while aligning their organizations to adapt

More information

Business Planning, Intangible Assets and Finance

Business Planning, Intangible Assets and Finance Business Planning, Intangible Assets and Finance Dr. Guriqbal Singh Jaiya Director Small and Medium-Sized Enterprises Division World Intellectual Property Organization www.wipo.int/sme Lifecycle of a Startup

More information

Product Lifecycle Management Through Patents

Product Lifecycle Management Through Patents Product Lifecycle Management Through Patents Strategic planning is not just for bit pharma anymore. Specialty pharma, drug delivery, biotech and even generic companies can all greatly benefit from careful

More information

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy

More information

Intellectual Property & Technology Commercialization Basics

Intellectual Property & Technology Commercialization Basics Intellectual Property & Technology Commercialization Basics Judith Sheft Assistant Vice President Technology Development NJIT (973) 596-5825 Sheft@njit.edu Disclaimer I am not a lawyer What is Intellectual

More information

MEDICAL DEVICE & DIAGNOSTICS

MEDICAL DEVICE & DIAGNOSTICS to Guide Strategic Medical Device and Introduction Medical device and diagnostic makers face myriad challenges when developing a new product, including working within resource and financial constraints,

More information

Spinnovator Public Private Partnership for Spin-offs

Spinnovator Public Private Partnership for Spin-offs A project of Ascenion and Vesalius Biocapital supported by the BMBF 5th International VPM Days Hannover Spinnovator Public Private Partnership for Spin-offs Christian Stein, September 1, 2011 Ascenion

More information

Company: What s It All About? September 25 th, 2008

Company: What s It All About? September 25 th, 2008 From Graduate School to Start-Up Company: What s It All About? September 25 th, 2008 1 Who am I? UNC Chemistry Ph.D. program 2001-2005 DeSimone Lab Co-Founder and Principle Technologist, Liquidia Technologies

More information

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement FOR IMMEDIATE RELEASE Ref 05AFF05 Contacts for Affitech: Contacts for XOMA Affitech (Norway): Investor Inquiries Dr. Martin Welschof Ellen M Martin Chief Executive Officer Kureczka/Martin Associates Phone:

More information

The University of Texas at Austin - Portugal An international partnership in graduate education, research, and technology commercialization

The University of Texas at Austin - Portugal An international partnership in graduate education, research, and technology commercialization The University of Texas at Austin - Portugal An international partnership in graduate education, research, and technology commercialization Technical Appendix to the Memorandum of Understanding toward

More information

Keys To IP Collaborations With Universities: Part 3

Keys To IP Collaborations With Universities: Part 3 Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Keys To IP Collaborations With Universities: Part

More information

NIH Center for Regenerative Medicine

NIH Center for Regenerative Medicine Catalyzing stem cell-based translation and therapy development Story Landis, Ph.D. Director, National Institute of Neurological Disorders and Stroke Council of Councils Meeting August 15, 2011 Center for

More information

Valuation Practice. ICM Advisors. Intellectual Property & Intangible Assets. Leverage the intangible assets INTELLECTUAL CAPITAL MANAGEMENT

Valuation Practice. ICM Advisors. Intellectual Property & Intangible Assets. Leverage the intangible assets INTELLECTUAL CAPITAL MANAGEMENT Valuation Practice Intellectual Property & Intangible Assets ICM Advisors INTELLECTUAL CAPITAL MANAGEMENT Leverage the intangible assets Business needs drive IP Valuation Intellectual Property (IP) and

More information

CDRD and the MSSC Seek Collaborative Projects to Discover and Develop New Treatments for Progressive Multiple Sclerosis

CDRD and the MSSC Seek Collaborative Projects to Discover and Develop New Treatments for Progressive Multiple Sclerosis CDRD and the MSSC Seek Collaborative Projects to Discover and Develop New Treatments for Progressive Multiple Sclerosis The Centre for Drug Research and Development (CDRD) and the Multiple Sclerosis Society

More information

The Intellectual Property in the collaboration between Public Research Organisations and industry

The Intellectual Property in the collaboration between Public Research Organisations and industry The Intellectual Property in the collaboration between Public Research Organisations and industry Nowadays new patterns of industrial innovation have emerged (often referred to as Open Innovation model)

More information

GLOBAL STARTUP PROGRAM

GLOBAL STARTUP PROGRAM GLOBAL STARTUP PROGRAM Terms of Reference NATIONAL CALL 2015-2016 May 2015 Powered by Supported by 2015 IC 2 Institute Proprietary 2015 IC 2 Institute Proprietary 1 Chapter I - Objective and scope ARTICLE

More information

Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd.

Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd. Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd. Roche recognizes changes in China Strong economic development

More information

Chemical safety and big data: the industry s demands

Chemical safety and big data: the industry s demands Chemical safety and big data: the industry s demands Richard CURRIE Senior Technical Expert; Group Leader & Global Predictive and Computational Toxicology Lead Valid results Useful results Credit Money/Grants

More information

Business process overview and due diligence checklist to assess new small business funding opportunities

Business process overview and due diligence checklist to assess new small business funding opportunities Business process overview and due diligence checklist to assess new small business funding opportunities Foundations that fund medical research increasingly have and are taking the opportunity to fund

More information

Intellectual Property. MGPA s Industry Experience program Spring 2012

Intellectual Property. MGPA s Industry Experience program Spring 2012 Intellectual Property MGPA s Industry Experience program Spring 2012 Intellectual Property (IP): Legal Protection for Intangible Assets Copyright Patent Trademark and Trade Secrets 2 Copyright Creative

More information

Entrepreneurs Assess Their M&A Options

Entrepreneurs Assess Their M&A Options 2015 SURVEY RESULTS Entrepreneurs Assess Their M&A Options Research among business leaders reveals excitement about future transactions and positive outlook for near-term M&A. INTRODUCTION Creating value

More information

We use Reaxys intensively for hit identification, hit-to-lead and lead optimization.

We use Reaxys intensively for hit identification, hit-to-lead and lead optimization. CASE STUDY Dr. Fabio C. Tucci, COO of Epigen Biosciences We use Reaxys intensively for hit identification, hit-to-lead and lead optimization. CREATING NEW ASSETS Epigen Biosciences is a start-up pharmaceutical

More information

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor The Biotech Business Life Cycle and The Lawyer s Role as Counselor and Advisor ASU February 15, 2010 1 BIOTECH BUSINESS CYCLE AN INTERDISCIPLINARY APPROACH TO LEGAL REPRESENTATION Intellectual Property

More information

TOPIC: UMUC Request for Approval of Creation and Investment in a New Company to Commercialize Analytics Technology and Services

TOPIC: UMUC Request for Approval of Creation and Investment in a New Company to Commercialize Analytics Technology and Services BOARD OF REGENTS SUMMARY OF ITEM FOR ACTION, INFORMATION OR DISCUSSION TOPIC: UMUC Request for Approval of Creation and Investment in a New Company to Commercialize Analytics Technology and Services COMMITTEE:

More information

ROLE OF THE INTELLECTUAL PROPERTY SYSTEM IN DEVELOPMENT AND MARKETING OF NEW PRODUCTS

ROLE OF THE INTELLECTUAL PROPERTY SYSTEM IN DEVELOPMENT AND MARKETING OF NEW PRODUCTS ROLE OF THE INTELLECTUAL PROPERTY SYSTEM IN DEVELOPMENT AND MARKETING OF NEW PRODUCTS Introduction Guriqbal Singh Jaiya Deputy Director, Small and Medium-Sized Enterprises Division World Intellectual Property

More information

04.25.08. Shahin Farshchi, Ph.D. Associate shahin.farshchi@luxcapital.com. shahin.farshchi@luxcapital.com

04.25.08. Shahin Farshchi, Ph.D. Associate shahin.farshchi@luxcapital.com. shahin.farshchi@luxcapital.com An Introduction to Technology Commercialization and Venture Capital 04.25.08 Shahin Farshchi, Ph.D. Associate 1 Talking Points I. Roadmap from the lab to the marketplace II. Who VCs are and how VC works

More information

Zenith: A Strategic Funding Journey for Tech CEOs

Zenith: A Strategic Funding Journey for Tech CEOs Zenith: A Strategic Funding Journey for Tech CEOs An initiative of the ISA Software Skillnet in association with the Irish Software Association and the Irish Management Institute Do you have the knowle

More information

The M&A Process and the Role of a Financial Advisor

The M&A Process and the Role of a Financial Advisor The M&A Process and the Role of a Financial Advisor My Background 1996 University of Florida undergrad with BS in Finance 1998 Geneva Companies / sub of Citigroup doing small M&A deals 1999 University

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

FOR SUCCESS YOUR PRESCRIPTION SPEAK. Business

FOR SUCCESS YOUR PRESCRIPTION SPEAK. Business YOUR PRESCRIPTION FOR SUCCESS Georgia is on the pulse of bioscience. After all, the industry has a $7.5 billion impact on our GDP and employs more than 70,000 people in our state. Find out why 300-plus

More information

Brand Quality with Asian Advantages

Brand Quality with Asian Advantages Brand Quality with Asian Advantages ScinoPharm Taiwan, Ltd. No.1, Nan-Ke 8th Road, Tainan Science Park, Shan-Hua, Tainan, 74144, Taiwan TEL : 886-6-505-2888 FAX : 886-6-505-2898 Email Contact : mkt@scinopharm.com

More information

Innovation & Quality for Higher Competitiveness of Companies

Innovation & Quality for Higher Competitiveness of Companies Innovation & Quality for Higher Competitiveness of Companies www.wipro.com DEVENDER MALHOTRA & SHALABH SRIVASTAVA WIPRO BPO Table of Contents Introduction...1 Understanding Innovation...2 Enablers of Innovation...2

More information

OFFICE OF ENTREPRENEURIAL AFFAIRS AND TECHNOLOGY COMMERCIALIZATION

OFFICE OF ENTREPRENEURIAL AFFAIRS AND TECHNOLOGY COMMERCIALIZATION OFFICE OF ENTREPRENEURIAL AFFAIRS AND TECHNOLOGY COMMERCIALIZATION Vision: The Office of Entrepreneurial Affairs and Technology Commercialization will be a fully integrated unit that serves as a one-stop

More information

Lally Workshops 2012 Lois S Peters

Lally Workshops 2012 Lois S Peters Lally Workshops 2012 Lois S Peters Endless possibilities Nanotechnology Programmable Matter Photonics (optoelectronics) MEMs Photovoltaics APT Advanced Propulsion Technology (thermal-cycle technology)

More information

Key Steps Before Talking to Venture Capitalists

Key Steps Before Talking to Venture Capitalists Key Steps Before Talking to Venture Capitalists Some entrepreneurs may not be familiar with raising institutional capital to grow their businesses. Expansion plans beyond common organic growth are typically

More information

Investing in Invention TM

Investing in Invention TM To Promote the Progress of Useful Arts Investing in Invention TM Peter N. Detkin Founder, Vice Chairman, Intellectual Ventures 1 A THRIVING MARKETPLACE FOR IDEAS Current market undervalues invention and

More information

Impact & Innovation in H2020 IP Management & Exploitation

Impact & Innovation in H2020 IP Management & Exploitation Impact & Innovation in H2020 IP Management & Exploitation Jörg Scherer Tallinn 04 March 2015 Get your ticket to innovation. Author: expert Dr. Eugene Sweeney 36 years experience of commercialising IP/research

More information

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education Curriculum Vitae Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details Private Address: Date, Place of Birth: Marital Status: Nationality: Languages: Stresemannstraße 9, 93477 Maintal, Germany, Tel. +49

More information

Office of Research Strategic Plan November 4, 2013

Office of Research Strategic Plan November 4, 2013 Office of Research Strategic Plan November 4, 2013 SOUTH DAKOTA STATE UNIVERSITY Vision: As a leading land-grant university, South Dakota State University will champion the public good through engaged

More information

Raytheon and Vista Equity Partners form new cybersecurity company

Raytheon and Vista Equity Partners form new cybersecurity company Raytheon and Vista Equity Partners form new cybersecurity company Investor Presentation April 20, 2015 Dial In Number 866.825.3209 Domestic 617.213.8061 International Reservation Number: 48245306 Replay

More information

CJS Winter Investor Conference January 14, 2015

CJS Winter Investor Conference January 14, 2015 CJS Winter Investor Conference January 14, 2015 Forward Looking Statements This presentation contains certain forward-looking statements concerning the Company's operations, performance, and financial

More information

Spear Alliance: Company Overview

Spear Alliance: Company Overview Spear Alliance Spear Alliance: Company Overview OUR STRATEGIES, YOUR SOLUTIONS Why we Exist? We exist to help leaders building the productive business through strategic and sustainable approach 2 Company

More information

Hitachi Announces 2018 Mid-term Management Plan

Hitachi Announces 2018 Mid-term Management Plan FOR IMMEDIATE RELEASE Hitachi Announces 2018 Mid-term Management Plan Tokyo, May 18, 2016 --- Hitachi, Ltd. (TSE:6501) today announced that it has formulated a management plan 2018 Mid-term Management

More information

Surprising Business Value from New Metrics of Sustainability

Surprising Business Value from New Metrics of Sustainability Surprising Business Value from New Metrics of Sustainability Co-Produced by R Edited by Expense Reduction Opportunities INCOME STATEMENT Revenue Growth Potential FOSSIL FUEL INTENSITY & CO 2 CARBON EMISSIONS

More information

Project Management. Dissemination and Exploitation Services in Horizon 2020

Project Management. Dissemination and Exploitation Services in Horizon 2020 Project Management Dissemination and Exploitation Services in Horizon 2020 Ontwerp: Studio Edwin de Boer 2 Project Management Dissemination and Exploitation Services in Horizon 2020 ttopstart - Project

More information

IP Valuation. WIPO Workshop on Innovation, Intellectual Asset Management and Successful Technology Licensing: Wealth Creation in the Arab Region

IP Valuation. WIPO Workshop on Innovation, Intellectual Asset Management and Successful Technology Licensing: Wealth Creation in the Arab Region IP Valuation WIPO Workshop on Innovation, Intellectual Asset Management and Successful Technology Licensing: Wealth Creation in the Arab Region Muscat, Oman, December 12 and 13, 2011 Topics Intangibles

More information

NTT. NTT clouds overview

NTT. NTT clouds overview NTT NTT clouds overview The NTT Group companies There is a reason why the NTT Group comprises a very select group of global technology companies. It is not just that we excel in delivering our products,

More information

INVESTING IN ALTERNATIVE ENERGY INVESTMENT CASE STUDY

INVESTING IN ALTERNATIVE ENERGY INVESTMENT CASE STUDY Institution of Mechanical Engineers INVESTING IN ALTERNATIVE ENERGY INVESTMENT CASE STUDY Friday 1 st February 2008 Philip M. Johnson, Chief Executive LIFE IC Limited, Tel: 0114 254 1270 mailto: philip.johnson@life-ic.com

More information

Business Planning. Paulo Soares de Pinho FEUNL. March,

Business Planning. Paulo Soares de Pinho FEUNL. March, Business Planning Paulo Soares de Pinho FEUNL March, 19 2014 1 Key Elements The Opportunity The Context The Team The Deal 2 It is not the technology - only 3 Business Plans 4 5 The Business Plan At startup

More information

WHO IS HD VEST? SUPPORTING ADVISORS WHO SUPPORT YOU

WHO IS HD VEST? SUPPORTING ADVISORS WHO SUPPORT YOU WHO IS HD VEST? SUPPORTING ADVISORS WHO SUPPORT YOU HD VEST A QUIET BRAND WITH A BIG PRESENCE For the last 30 years of our firm s history, our sole purpose has been to support independent Advisors providing

More information

Texas Infrastructure Council Planning and building the future for Texas' infrastructure

Texas Infrastructure Council Planning and building the future for Texas' infrastructure TXIC Texas Infrastructure Council Planning and building the future for Texas' infrastructure Texas Infrastructure Council Mission To support state and local governments in the formation and implementation

More information

How to set up a successful university startup incubator

How to set up a successful university startup incubator How to set up a successful university startup incubator November 2014 Company Proven infactories the US as a model for nurturing young companies, start-up incubators are now thriving in Europe. But is

More information

CLINICAL DEVELOPMENT OPTIMIZATION

CLINICAL DEVELOPMENT OPTIMIZATION PAREXEL CLINICAL RESEARCH SERVICES CLINICAL DEVELOPMENT OPTIMIZATION Enhancing the clinical development process to achieve optimal results ADVANCED TECHNOLOGY COMBINED WITH INTELLIGENT THINKING CAN HELP

More information

How to set up a successful university startup incubator

How to set up a successful university startup incubator How to set up a successful university startup incubator October 2014 Company Proven infactories the US as a model for nurturing young companies, start-up incubators are now thriving in Europe. But is there

More information

Your ideal partner in commercializing inventions!

Your ideal partner in commercializing inventions! Your ideal partner in commercializing inventions! It is not enough to merely have more ideas than others; one must also have the ability to decide which of these ideas are good. Linus Carl Pauling (1901-94),

More information

Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices. Professor Stanley Kowalski

Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices. Professor Stanley Kowalski Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices Professor Stanley Kowalski Overview: Technology Transfer Defined Mission and Policy Statutory

More information

How Do Venture Capital Investors Add Value To Portfolio Companies?

How Do Venture Capital Investors Add Value To Portfolio Companies? This article first appeared in slightly modified form in Top Capital October 2007 Capital Investors Add by Joseph Chan Corporate & Securities Joseph Chan +86.21.63351128 joseph.chan@pillsburylaw.com Joseph

More information

2015 Russian Nanotechnology Investment Enabling Technology Leadership Award

2015 Russian Nanotechnology Investment Enabling Technology Leadership Award 2015 Russian Nanotechnology Investment Enabling Technology Leadership Award 2015 Contents Background and Company Performance... 3 Technology Leverage and Customer Impact of OJSC RUSNANO... 3-5 Conclusion...

More information

Rules and Regulations

Rules and Regulations Rules and Regulations Article 1 Objectives 1.1 The Call For Entrepreneurship is a systematic and agile process for the assessment of projects for capital venture investment within the scope of Portugal

More information

Customer effectiveness

Customer effectiveness www.pwc.com/sap Customer effectiveness PwC SAP Consulting Services Advance your ability to win, keep and deepen relationships with your customers. Are your customers satisfied? How do you know? Five leading

More information

India USA South Africa

India USA South Africa ISO 9001:2008 & ISO/IEC 27001:2005 Certified Company Brick On Brick BOB Tech Solutions Pvt. Ltd. 3/4, 1st Floor, Maruti Towers, Hosur Road, Madiwala, Bangalore 560068 Tel - + 91 80-4001 6000 www.bobtechsolutions.com

More information

Financing Growth Ventures to Minimize Equity Dilution

Financing Growth Ventures to Minimize Equity Dilution Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth

More information

Technology Consulting Sathguru. Technology Management Services

Technology Consulting Sathguru. Technology Management Services Management Services Intellectual Property and Enterprises In today s global innovation economy, Intellectual Property (IP) is a key factor for businesses. Turning ideas into business assets with real market

More information

University Proof of Concept & Seed Funds

University Proof of Concept & Seed Funds University Proof of Concept & Seed Funds Introduction to Isis 2 Introduction to Proof of Concept & Seed Funds 3 Key facts about the Funds 4 Applying to the Funds 5 Fund Application Process Flowchart 8

More information

Indian Fashion Retail Landscape

Indian Fashion Retail Landscape Indian Fashion Retail Landscape Contents Art of Building Fashion Brands 01 Explosive Growth of Premium and Luxury Fashion Business 03 Less is More 05 International Brands and Sourcing Strategies 07 Fashion

More information

Poxel Raises 16 million in a Series A Financing to Accelerate Pipeline Development

Poxel Raises 16 million in a Series A Financing to Accelerate Pipeline Development Poxel Raises 16 million in a Series A Financing to Accelerate Pipeline Development Lyon, France, July 8, 2010 -, a diabetes drug development specialist, announces today that it has raised 16 million (USD

More information